NEW YORK (360Dx) – Astute Medical said today that it has inked separate agreements with Ortho Clinical Diagnostics and BioMérieux aimed at expanding access to Astute's NephroCheck test, a biomarker-based risk assessment tool for acute kidney injury.

Astute has expanded its European distribution deal with Ortho that expands the number of countries with access to the test. The firm also inked a distribution agreement with BioMérieux that builds on an existing licensing and collaboration agreement.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.